A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer by Scagliotti, Giorgio V, Germonpré, Paul, Bosquée, Leon, Vansteenkiste, Johan, Gervais, R, Planchard, David, Reck, Martin, De Marinis, Filippo, Lee, Jin Soo, Park, Keunchil, Biesma, Bonne, Gans, Steven, Ramlau, R, Szczesna, Aleusandra, Makhson, A, Manikhas, G, Morgan, Bruno, Zhu, Y, Chan, Kai C, von Pawel, Joachim

Get full text